| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Medical Biochemistry, Goteborg University, Gothenburg, Sweden
2 Proteome Systems Ltd, Sydney, NSW, Australia
3 Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina, Chapel Hill, NC, USA
4 Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina, Chapel Hill, NC, USA; Department of Cell and Molecular Physiology, University of North Carolina, Chapel Hill, NC, USA
5 Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina, Chapel Hill, NC, USA; Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, NC, USA
* To whom correspondence should be addressed. E-mail: cwdavis{at}med.unc.edu.
A longstanding question in obstructive airways disease is whether observed changes in mucin composition and/or post-translational glycosylation are due to genetic or to environmental factors. We tested whether the mucins secreted by second passage primary human bronchial epithelial (HBE) cell cultures derived from non-CF or CF patients have intrinsically different specific mucin compositions, and whether these mucins are glycosylated differently. Both CF and non-CF cultures produced MUC5B, predominantly, as judged by quantitative agarose gel Western blots with mucin-specific antibodies: MUC5B was present at ~10-fold higher levels than MUC5AC, consistent with our previous mRNA studies (Am J Respir Cell Mol Biol 20:595-604, 1999). O-linked oligosaccharides released from purified non-CF and CF mucins and studied by HPLC-mass spectrometry had highly variable glycan structures and there were no observable differences between the two groups. Hence, there were no differences in either the specific mucins or their O-glycans that correlated with the CF phenotype under the non-inflammatory conditions of cell culture. We conclude that the differences observed in the mucins sampled directly from patients is most likely due to environmental factors relating to infection and/or inflammation.
This article has been cited by other articles:
|
|
 |
|
  N. G Karlsson and K. A Thomsson Salivary MUC7 is a major carrier of blood group I type O-linked oligosaccharides serving as the scaffold for sialyl Lewis x Glycobiology, March 1, 2009; 19(3): 288 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Voynow and B. K. Rubin Mucins, Mucus, and Sputum Chest, February 1, 2009; 135(2): 505 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kesimer, S. Kirkham, R. J. Pickles, A. G. Henderson, N. E. Alexis, G. DeMaria, D. Knight, D. J. Thornton, and J. K. Sheehan Tracheobronchial air-liquid interface cell culture: a model for innate mucosal defense of the upper airways? Am J Physiol Lung Cell Mol Physiol, January 1, 2009; 296(1): L92 - L100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kesimer and J. K Sheehan Analyzing the functions of large glycoconjugates through the dissipative properties of their absorbed layers using the gel-forming mucin MUC5B as an example Glycobiology, June 1, 2008; 18(6): 463 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhu, C. Ehre, L. H. Abdullah, J. K. Sheehan, M. Roy, C. M. Evans, B. F. Dickey, and C. W. Davis Munc13-2-/- baseline secretion defect reveals source of oligomeric mucins in mouse airways J. Physiol., April 1, 2008; 586(7): 1977 - 1992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H. Abdullah and C. W. Davis Regulation of airway goblet cell mucin secretion by tyrosine phosphorylation signaling pathways Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L591 - L599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Ross, L. A. Dailey, L. E. Brighton, and R. B. Devlin Transcriptional Profiling of Mucociliary Differentiation in Human Airway Epithelial Cells Am. J. Respir. Cell Mol. Biol., August 1, 2007; 37(2): 169 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L Schulz, A. J Sloane, L. J Robinson, S. S Prasad, R. A Lindner, M. Robinson, P. T Bye, D. W Nielson, J. L Harry, N. H Packer, et al. Glycosylation of sputum mucins is altered in cystic fibrosis patients Glycobiology, July 1, 2007; 17(7): 698 - 712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Matsui, V. E. Wagner, D. B. Hill, U. E. Schwab, T. D. Rogers, B. Button, R. M. Taylor II, R. Superfine, M. Rubinstein, B. H. Iglewski, et al. A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms PNAS, November 28, 2006; 103(48): 18131 - 18136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. W. Williams, A. Sharafkhaneh, V. Kim, B. F. Dickey, and C. M. Evans Airway Mucus: From Production to Secretion Am. J. Respir. Cell Mol. Biol., May 1, 2006; 34(5): 527 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Grubb, T. D. Rogers, P. C. Diggs, R. C. Boucher, and L. E. Ostrowski Culture of murine nasal epithelia: model for cystic fibrosis Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L270 - L277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Rose and J. A. Voynow Respiratory Tract Mucin Genes and Mucin Glycoproteins in Health and Disease Physiol Rev, January 1, 2006; 86(1): 245 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-H. Leir, S. Parry, T. Palmai-Pallag, J. Evans, H. R. Morris, A. Dell, and A. Harris Mucin Glycosylation and Sulphation in Airway Epithelial Cells Is Not Influenced by Cystic Fibrosis Transmembrane Conductance Regulator Expression Am. J. Respir. Cell Mol. Biol., May 1, 2005; 32(5): 453 - 461. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
